Navigation Links
Nanomedical Diagnostics Announces Office Move to Accommodate Company Growth
Date:12/10/2018

Nanomedical Diagnostics, leading producer of graphene biosensors for pharmaceutical and biotherapeutics research, announces a headquarters relocation to 9640 Towne Centre Drive, Suite 100, effectively tripling its space from 5,200 to 16,500 square feet.

“This past year has seen exponential growth, both domestically and internationally, for the sales of our drug discovery platforms. We’re in the great position of having to move to a new space to accommodate expanded production and R&D,” says Nanomedical Diagnostics CEO, Ross Bundy. “Our new building enables better operational efficiencies for our production lines and brings departments that were formerly separated in different locations together under one roof. This allows for better collaboration and innovation as we launch new products and grow our staff.”

The company’s move places it in the heart of the biotech sector in San Diego, providing closer proximity to key customers, as well as additional amenities such as large meeting rooms, a reception area, and exercise facilities. The versatile building is equipped to support a large R&D laboratory, shipping and delivery staging, expanded production capacity, and additional office staff.

“2019 promises to be an exciting year for the company,” continues Mr. Bundy. “We’re launching a new high-throughput drug discovery product early in the year and are in the process of hiring in all departments to support increased sales. We are also expanding our line of industrial OEM graphene sensors for use by partners in diverse industries and are thrilled to find a space that can accommodate our projected growth over the next few years.”

Nanomedical Diagnostics’ official move date is December 10, 2018.

About Nanomedical Diagnostics

Nanomedical Diagnostics (“Nanomed”) is a life science company based in San Diego, CA. As the world’s leading manufacturer and developer of next-generation graphene biosensors, Nanomed’s mission is to transform the healthcare industry with innovative new products that enable cutting-edge life science research, drug discovery applications, and portable diagnostic and health monitoring platforms.

Read the full story at https://www.prweb.com/releases/nanomedical_diagnostics_announces_office_move_to_accommodate_company_growth/prweb15966943.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Combined with BONCAT, Nanomedical Diagnostics Graphene Biosensor Identifies Circulating Biomarkers of Aging
2. Nanomedical Diagnostics Agile R100 Graphene Biosensor Characterizes Difficult-to-Study MYC Oncoprotein for Cancer Research
3. LabRoots Produces 9th Annual Clinical Diagnostics & Research Virtual Conference Showcasing Developments in Laboratory Testing, Patient Care and Treatment
4. Abbott Diagnostics Features Advanced Optical Hematology Technology for Elevated Analytical Performance, in Informative Webinar
5. Fuzionaire Diagnostics Announces Disease-Agnostic Platform to Radiolabel Any Molecule for Disease Diagnosis and Drug Discovery
6. DNAnexus and QIAGEN Team Up in Education Webinar: Scaling End-to-End NGS Solutions for Clinical Diagnostics in the Cloud
7. Plum Alley Closes $1.5M in Syndicate with Women and Men Investing in CRISPR-based Diagnostics Company
8. Heart Health Innovator Boston Heart Diagnostics Joins American College of Lifestyle Medicine Corporate Roundtable
9. Singulex and Thermo Fisher Scientific Enter into License and Supply Agreement to bring Next Generation Immunodiagnostics to Sepsis and SIRS Diagnostics
10. Force Diagnostics and higi Partner to Provide Innovative Services to Life Insurance Industry:
11. Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2015 to 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2020)... (PRWEB) , ... May 29, 2020 , ... ... of digital transformation for enterprises globally, has collaborated with EchoNous Inc. to develop ... It can measure systolic heart function, which has been clinically tested versus ...
(Date:5/28/2020)... ... May 28, 2020 , ... Actuate Therapeutics, Inc. (Actuate), ... Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be presented at this year’s ... on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s principal investigator on the ...
(Date:5/21/2020)... ... May 19, 2020 , ... ... management solutions, today introduced BioMed to their award-winning computerized maintenance management system ... the people and systems around biomedical engineering to better allocate staff time, ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... ... 21, 2020 , ... Ripple Science today announced new initiatives ... are working remotely and have paused patient visits, forcing teams to do more ... during this uncertain time by giving research teams free access to Ripple for ...
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , leading developer of direct-to-consumer ... Early Gender DNA Tests sold in March, just months after attaining the 150,000-test ... product, where a mom could order her kit online, collect a DNA sample from ...
(Date:4/1/2020)... ... March 30, 2020 , ... Kinetic Vet, an ... an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within the animal health ... activity against microorganisms for up to 90 days. , In addition to reducing ...
(Date:4/1/2020)... , ... March 31, 2020 ... ... Systems, B.V. (MBS) has developed a method using its revolutionary NEXTGENPCR endpoint ... minutes. Combined with smaller reaction volumes, increased samples per run, and standard, ...
Breaking Biology Technology: